In addition, administration of recombinant Gal-9 ameliorates disease activity in various animal models of autoimmunity, including collagen induced arthritis and autoimmune diabetes [6, 7], by inhibiting the adhesion of inflammatory cells [9]. This evidence concerns the gene LGALS9 and Autoimmunity.